Skip navigation

Regulation & Licensing of Medicines - reforms in light of Seroxat

This is an invitation-only meeting of the Institute's Product Liability Forum.

23rd October 2008

This is an invitation-only meeting of the Institute's Product Liability Forum.

This seminar is organized with the MHRA on the topic of pharmaceutical regulation and medicines licensing. The aim of our seminar is to look in a dispassionate way at broader issues arising from the Seroxat investigation, in particular the inadequacies of the legislative framework & ways in which this can be ameliorated. This will be a rare opportunity to discuss issues relating to the regulation of medicines with the Chief Executive of the MHRA, Professor Kent Woods.

If you would like more information on this event or joining the Institute's Product Liability Forum, please contact Dr Duncan Fairgrieve or Faria Medjouba

The seminar will run between 17.00 and 19.00, followed by a dinner at the Travellers Club and will cost £85 per person.


23rd November 2017 | LONDON

The standard of review of national court decisions by investment tribunals

Read more

27th November 2017 | LONDON

40th FA Mann Lecture

Read more

4th December 2017 | LONDON

Harry Weinrebe Annual Lecture: Perspectives on 15 years in Business and Human Rights - and on where we may be going next

Read more

6th December 2017 | LONDON

16th Annual Review of the Arbitration Act

Read more

11th December 2017 | LONDON

Legal consequences of the separation of the Chagos Archipelago from Mauritius (ICJ Advisory Opinion)

Read more